News

The introduction of bacteria to a tumor’s microenvironment goes on to create the possibility of acute inflammation, which further triggers the immune system’s primary responder cells to attack rather than just protect the tumor, as per the researchers at...

It has come to light that patient with idiopathic intracranial hypertension- IIH can be treated with an injectable peptide used for type 2 diabetes. This has been found in a Phase II trial. As per the study’s latest findings,...

A quality clinical trial database is an essential part of any clinical trial. It helps to address challenges such as inaccurate data, lack of quality data, and managing the trial timeline. A well-built database also helps improve collaboration between...

Breaking Down the Medicare Part D Coverage Gap: What You Need to Know Medicare Part D is a prescription drug benefit program for individuals who are eligible for Medicare, which is a federal health insurance program for people who are...

Biocytogen Pharmaceuticals announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Under the agreement, Biocytogen grants Janssen and its affiliates a non-exclusive worldwide license to use...

Crown Bioscience , a global contract research organization and JSR Life Sciences company, announced the opening of a new location in Singapore to expand the company's capacity to serve both global and support local biotech and pharmaceutical companies engaged...

Lonza recently announced a significant enhancement to its powder characterization capabilities at its Small Molecules site in Tampa, Florida, US. The facility has been upgraded to include universal powder flow testing alongside automated particle size and shape analysis capabilities....